Chemotherapy is a life‐saving treatment for cancer patients, but also causes long‐term
cognitive impairment, or “chemobrain”, in survivors. However, several challenges, including …

Millions of cancer survivors experience a persistent neurological syndrome that includes
deficits in memory, attention, information processing, and mental health. Cancer therapy …

Chemotherapy can significantly prolong the survival of patients with breast cancer;
Nevertheless, the majority of patients receiving chemotherapy such as doxorubicin may …

Chemotherapy has significantly increased the number of cancer survivors. However,
chemotherapy itself carries various adverse effects that limit the efficacy of treatment and …

Since the first clinical trials conducted after World War II, chemotherapeutic drugs have been
extensively used in the clinic as the main cancer treatment either alone or as an adjuvant …

Rationale Chemotherapy-induced cognitive impairment (CICI), chemobrain, and chemofog
are the common terms for mental dysfunction in a cancer patient/survivor under the influence …

Among the potential adverse effects of breast cancer treatment, chemotherapy-related
cognitive impairment (CRCI) has gained increased attention in the past years. In this review …

Cognitive deficits are commonly reported by patients following treatment with
chemotherapeutic agents. Anthracycline-containing chemotherapy regimens are associated …

Breast cancer is the most common female malignancy in both the developed and
developing world. Doxorubicin is one of the most commonly used chemotherapies for breast …

Up to 50% of traumatic brain injury (TBI) survivors demonstrate persisting and late-onset
anxiety disorders indicative of limbic system dysregulation, yet the pathophysiology …